François Ghiringhelli

1. The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
   2007/10/30 by Lionel Apétoh, Lionel Apetoh, François Ghiringhelli +14 · 5 citations
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Advanced Glycation End Products research #Immune Response and Inflammation #Immunotherapy and Immune Responses
2. Immunogenic death of colon cancer cells treated with oxaliplatin
   2009/11/02 by Antoine Tesnière, A Tesniere, F. Schlemmer +31 · 4 citations
   Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Drug Transport and Resistance Mechanisms #Immunotherapy and Immune Responses
3. First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration
   2024/09/16 by Jordi Rodón, J. Rodon, H. Prenen +33 · 1 voice · 3 citations
   Biochemistry, Genetics and Molecular Biology · #Cancer-related gene regulation #Polyamine Metabolism and Applications #Virus-based gene therapy research